HK1202260A1 - 宿醉的預防劑及/或治療劑 - Google Patents

宿醉的預防劑及/或治療劑

Info

Publication number
HK1202260A1
HK1202260A1 HK15102804.5A HK15102804A HK1202260A1 HK 1202260 A1 HK1202260 A1 HK 1202260A1 HK 15102804 A HK15102804 A HK 15102804A HK 1202260 A1 HK1202260 A1 HK 1202260A1
Authority
HK
Hong Kong
Prior art keywords
veisalgia
treating
preventing
agent
treating veisalgia
Prior art date
Application number
HK15102804.5A
Other languages
English (en)
Inventor
田中徹
中島元夫
安部史紀
河田聰史
Original Assignee
Sbi Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbi Pharmaceuticals Co Ltd filed Critical Sbi Pharmaceuticals Co Ltd
Publication of HK1202260A1 publication Critical patent/HK1202260A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK15102804.5A 2011-12-07 2015-03-18 宿醉的預防劑及/或治療劑 HK1202260A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011267841 2011-12-07
PCT/JP2012/081080 WO2013084816A1 (ja) 2011-12-07 2012-11-30 二日酔いの予防剤及び／又は治療剤

Publications (1)

Publication Number Publication Date
HK1202260A1 true HK1202260A1 (zh) 2015-09-25

Family

ID=48574184

Family Applications (2)

Application Number Title Priority Date Filing Date
HK18115886.5A HK1256803A1 (zh) 2011-12-07 2015-03-18 宿醉的預防劑及/或治療劑
HK15102804.5A HK1202260A1 (zh) 2011-12-07 2015-03-18 宿醉的預防劑及/或治療劑

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK18115886.5A HK1256803A1 (zh) 2011-12-07 2015-03-18 宿醉的預防劑及/或治療劑

Country Status (8)

Country Link
US (2) US20140343140A1 (zh)
EP (1) EP2789336B1 (zh)
JP (1) JP5809291B2 (zh)
CN (2) CN104144686A (zh)
HK (2) HK1256803A1 (zh)
RU (1) RU2593365C2 (zh)
TW (1) TWI571455B (zh)
WO (1) WO2013084816A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10449353B2 (en) 2016-04-28 2019-10-22 Medtronic, Inc. Electrode assemblies, methods, and components thereof for implantable medical electrical leads
JPWO2018043240A1 (ja) 2016-09-02 2019-06-24 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸類を含む水性製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4966665B2 (ja) * 2003-11-19 2012-07-04 オメガ バイオ−ファーマ （アイ．ピー．１） リミテッド アルコール代謝を改善し、二日酔いの影響を軽減するための材料と方法
CA2752569C (en) * 2004-09-02 2014-09-16 Cosmo Oil Co., Ltd. .delta.-amino acid as an exercise function-improving agent
JP2007192659A (ja) * 2006-01-19 2007-08-02 Sogo Ikagaku Kenkyusho:Kk 疲労度評価方法およびその利用
CA2722578C (en) * 2008-05-14 2014-02-11 Sbi Alapromo Co., Ltd. Use of .delta.-amino levulinic acid to treat male infertility
JP2009143939A (ja) * 2009-01-27 2009-07-02 Tsujido Chemical Corp 治療剤
WO2011161220A1 (en) * 2010-06-23 2011-12-29 Photocure Asa Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
CN103747784B (zh) * 2011-08-12 2018-01-30 思佰益药业股份有限公司 败血症的预防剂和/或治疗剂
JP5907357B2 (ja) * 2011-10-12 2016-04-26 Ｓｂｉファーマ株式会社 移植臓器生着促進剤

Also Published As

Publication number Publication date
CN108743574A (zh) 2018-11-06
JPWO2013084816A1 (ja) 2015-04-27
EP2789336A4 (en) 2015-05-27
US10022345B2 (en) 2018-07-17
CN104144686A (zh) 2014-11-12
EP2789336B1 (en) 2016-12-14
TWI571455B (zh) 2017-02-21
RU2593365C2 (ru) 2016-08-10
US20160081957A1 (en) 2016-03-24
EP2789336A1 (en) 2014-10-15
TW201323382A (zh) 2013-06-16
JP5809291B2 (ja) 2015-11-10
RU2014126564A (ru) 2016-01-27
HK1256803A1 (zh) 2019-10-04
WO2013084816A1 (ja) 2013-06-13
US20140343140A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
HK1214521A1 (zh) 用於治療蛋白質病的組合物和方法
AP3269A (en) Methods and compounds for treating paramyxoviridaevirus infections
HK1202486A1 (zh) 表面處理方法、表面處理劑及新型化合物
HK1201475A1 (zh) 治療疼痛的方法和組合物
HK1204988A1 (zh) 用於預防或治療眼科病狀的方法和組合物
HK1251796A1 (zh) 治療糖尿病的方法和組合物
EP2755614A4 (en) SYSTEMS AND METHOD FOR PROSTATE TREATMENT
IL227429A0 (en) The components and methods of cancer treatment
EP2757887A4 (en) PYRROLOPYRIDINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF HIV
EP2755482A4 (en) COMPOSITIONS AND METHODS OF TREATING CANCER
PL2807323T3 (pl) Kompozycja i sposób obróbki układów wodnych
HK1215170A1 (zh) 治療精神分裂症的方法和組合物
HK1209633A1 (zh) 治療糖尿病的組合物和方法
EP2544655A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN
EP2766009A4 (en) METHOD AND COMPOSITIONS FOR SKIN TREATMENT
IL232648A0 (en) Preparations and methods for treating glioma
GB201002083D0 (en) Apparatus for improving and/or maintaining numerical ability
EP2688402A4 (en) METHODS FOR THE TREATMENT OR PREVENTION OF UROLOGIC INFLAMMATION
IL229231A0 (en) Preparations and methods for the treatment of cancer
HK1197583A1 (zh) 預防和治療敗血症的方法
EP2907897A4 (en) SURFACE TREATMENT AGENT AND SURFACE TREATMENT METHOD
HK1183766A1 (zh) 用於治療瘀傷的組合物和方法
EP2708223A4 (en) COLORING AGENT AND USE THEREOF
EP2745838A4 (en) PROPHYLACTIC AGENT AND / OR THERAPEUTIC AGENT FOR SEPTICEMIA
HK1202260A1 (zh) 宿醉的預防劑及/或治療劑